X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA FULFORD INDIA ALEMBIC PHARMA/
FULFORD INDIA
 
P/E (TTM) x 28.1 398.8 7.1% View Chart
P/BV x 6.4 6.2 103.3% View Chart
Dividend Yield % 0.7 0.1 866.9%  

Financials

 ALEMBIC PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
FULFORD INDIA
Mar-14
ALEMBIC PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs792942 84.0%   
Low Rs443450 98.4%   
Sales per share (Unadj.) Rs167.0691.4 24.2%  
Earnings per share (Unadj.) Rs38.211.5 333.0%  
Cash flow per share (Unadj.) Rs42.015.4 273.4%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.60.3 225.5%  
Book value per share (Unadj.) Rs84.9380.0 22.3%  
Shares outstanding (eoy) m188.523.90 4,833.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.71.0 367.2%   
Avg P/E ratio x16.260.7 26.6%  
P/CF ratio (eoy) x14.745.3 32.4%  
Price / Book Value ratio x7.31.8 397.0%  
Dividend payout %10.517.4 60.1%   
Avg Mkt Cap Rs m116,3832,714 4,287.6%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m4,214505 834.4%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m31,4872,696 1,167.7%  
Other income Rs m55125 43.9%   
Total revenues Rs m31,5422,822 1,117.8%   
Gross profit Rs m10,060-46 -21,680.6%  
Depreciation Rs m72215 4,750.7%   
Interest Rs m3710 387.4%   
Profit before tax Rs m9,35654 17,230.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,16010 22,502.1%   
Profit after tax Rs m7,19445 16,094.6%  
Gross profit margin %31.9-1.7 -1,856.6%  
Effective tax rate %23.117.7 130.6%   
Net profit margin %22.81.7 1,378.3%  
BALANCE SHEET DATA
Current assets Rs m15,0661,738 866.7%   
Current liabilities Rs m7,674545 1,408.9%   
Net working cap to sales %23.544.3 53.0%  
Current ratio x2.03.2 61.5%  
Inventory Days Days6748 138.2%  
Debtors Days Days414 943.8%  
Net fixed assets Rs m8,23712 69,222.3%   
Share capital Rs m37739 966.7%   
"Free" reserves Rs m15,4161,443 1,068.4%   
Net worth Rs m16,0051,482 1,080.0%   
Long term debt Rs m00-   
Total assets Rs m24,5942,077 1,184.3%  
Interest coverage x255.26.7 3,800.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 98.6%   
Return on assets %29.42.6 1,126.6%  
Return on equity %44.93.0 1,490.3%  
Return on capital %58.74.3 1,363.0%  
Exports to sales %55.70-   
Imports to sales %10.424.5 42.6%   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283659 498.0%   
Fx inflow Rs m17,81117 103,549.4%   
Fx outflow Rs m5,318673 790.0%   
Net fx Rs m12,493-656 -1,904.5%   
CASH FLOW
From Operations Rs m9,30490 10,337.7%  
From Investments Rs m-3,105105 -2,968.3%  
From Financial Activity Rs m-1,959-14 13,894.3%  
Net Cashflow Rs m4,240181 2,349.0%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.9 3.8 76.3%  
FIIs % 9.1 0.1 9,100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 21.2 65.6%  
Shareholders   49,328 4,783 1,031.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   NOVARTIS  TORRENT PHARMA  STRIDES SHASUN LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 19, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS